Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,536 | 264,545 | 54,897 | 32,672 | 200,695 |
| Marketable Securities | 926,353 | 1,090,024 | 503,658 | 301,753 | 133,012 |
| Receivables | 592 | N/A | N/A | N/A | N/A |
| Inventories | 2,022 | N/A | N/A | N/A | N/A |
| TOTAL | $1,048,342 | $1,375,388 | $574,153 | $345,184 | $344,720 |
| Non-Current Assets | |||||
| PPE Net | 14,296 | 12,068 | 10,881 | 3,500 | 2,825 |
| Investments And Advances | 0 | 0 | 470 | 0 | 1,010 |
| Other Non-Current Assets | 63,619 | 47,136 | 49,849 | 3,492 | 2,460 |
| TOTAL | $77,915 | $59,204 | $61,200 | $6,992 | $6,295 |
| Total Assets | $1,126,257 | $1,434,592 | $635,353 | $352,176 | $351,015 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 41,770 | 21,469 | 23,196 | 15,351 | 8,468 |
| Accrued Expenses | 35,578 | 28,887 | 14,517 | 9,081 | 6,588 |
| Other current liabilities | N/A | N/A | N/A | N/A | 939 |
| TOTAL | $85,072 | $59,684 | $43,942 | $27,723 | $15,995 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,235 | 2,176 | 2,056 | 2,240 | N/A |
| Other Non-Current Liabilities | 45,292 | 45,399 | 47,555 | 2,024 | 3,076 |
| TOTAL | $49,102 | $50,103 | $52,305 | $8,125 | $3,076 |
| Total Liabilities | $134,174 | $109,787 | $96,247 | $35,848 | $19,071 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 104,705 | 93,049 | 69,596 | 53,909 | 47,785 |
| Common Shares | 2,407,757 | 2,275,952 | 1,191,831 | 759,432 | 607,581 |
| Retained earnings | -1,417,427 | -952,110 | -653,702 | -439,173 | -275,255 |
| Other shareholders' equity | 1,753 | 963 | 977 | -3,931 | -382 |
| TOTAL | $992,083 | $1,324,805 | $539,106 | $316,328 | $331,944 |
| Total Liabilities And Equity | $1,126,257 | $1,434,592 | $635,353 | $352,176 | $351,015 |